Real Time Genomics, Inc., the genome analytics company, and
Knome, Inc., the human genome interpretation company, today announced that the Real Time Genomics (RTG) Variant platform will be integrated into every shipment of the knoSYS™100 interpretation ...
[Published Bio-Medicine - May 06 2013]